These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34431799)

  • 41. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B
    Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.
    Hiniker A; Daniels BH; Lee HS; Margeta M
    Acta Neuropathol Commun; 2013 Jul; 1():29. PubMed ID: 24252466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sporadic Inclusion Body Myositis and Autoantibodies].
    Yamashita S; Ando Y
    Brain Nerve; 2018 Apr; 70(4):449-457. PubMed ID: 29632292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment.
    Schmidt K; Schmidt J
    Curr Opin Rheumatol; 2017 Nov; 29(6):632-638. PubMed ID: 28832349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
    Chahin N; Engel AG
    Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Where are we moving in the classification of idiopathic inflammatory myopathies?
    Tanboon J; Uruha A; Stenzel W; Nishino I
    Curr Opin Neurol; 2020 Oct; 33(5):590-603. PubMed ID: 32852298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis.
    Tasca G; Monforte M; De Fino C; Kley RA; Ricci E; Mirabella M
    Muscle Nerve; 2015 Dec; 52(6):956-62. PubMed ID: 25808807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
    Dourmishev LA
    Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current Classification and Management of Inflammatory Myopathies.
    Schmidt J
    J Neuromuscul Dis; 2018; 5(2):109-129. PubMed ID: 29865091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis.
    Kramp SL; Karayev D; Shen G; Metzger AL; Morris RI; Karayev E; Lam Y; Kazdan RM; Pruijn GJ; Saschenbrecker S; Dähnrich C; Schlumberger W
    Auto Immun Highlights; 2016 Dec; 7(1):16. PubMed ID: 27858337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.
    Damoiseaux J; Vulsteke JB; Tseng CW; Platteel ACM; Piette Y; Shovman O; Bonroy C; Hamann D; De Langhe E; Musset L; Chen YH; Shoenfeld Y; Allenbach Y; Bossuyt X
    Autoimmun Rev; 2019 Mar; 18(3):293-305. PubMed ID: 30639643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches.
    Mastaglia FL; Needham M
    J Clin Neurosci; 2015 Jan; 22(1):6-13. PubMed ID: 25510538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Recent progress in diagnosis and pathomechanism of inclusion body myositis].
    Aoki M; Suzuki N; Kato M; Warita H
    Rinsho Shinkeigaku; 2014; 54(12):1115-8. PubMed ID: 25672724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is it really myositis? Mimics and pitfalls.
    Bhai SF; Dimachkie MM; de Visser M
    Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101764. PubMed ID: 35752578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Recent Developments in Myositis Syndromes].
    Genth E
    Dtsch Med Wochenschr; 2018 Oct; 143(20):1472-1476. PubMed ID: 30286497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis.
    Pinal-Fernandez I; Casal-Dominguez M; Derfoul A; Pak K; Miller FW; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Carrion-Ribas C; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
    Ann Rheum Dis; 2020 Sep; 79(9):1234-1242. PubMed ID: 32546599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inclusion body myositis: clinical features and pathogenesis.
    Greenberg SA
    Nat Rev Rheumatol; 2019 May; 15(5):257-272. PubMed ID: 30837708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inclusion body myositis.
    Dimachkie MM; Barohn RJ
    Curr Neurol Neurosci Rep; 2013 Jan; 13(1):321. PubMed ID: 23250766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.